HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse

Engineering Human Peripheral Blood Stem Cell Grafts that Are Depleted of Naïve T Cells and Retain Functional Pathogen-Specific Memory T Cells

(2014) Marie Bleakley et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

"Designed" grafts for HLA-haploidentical stem cell transplantation

(2013) M. F. Martelli et al.   BLOOD

Umbilical cord blood transplantation: the first 25 years and beyond

(2013) K. K. Ballen et al.   BLOOD

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

(2013) Asad Bashey et al.   JOURNAL OF CLINICAL ONCOLOGY

Allogeneic Transplantation Versus Chemotherapy as Postremission Therapy for Acute Myeloid Leukemia: A Prospective Matched Pairs Analysis

(2013) Matthias Stelljes et al.   JOURNAL OF CLINICAL ONCOLOGY

Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies

(2012) P. Di Bartolomeo et al.   BLOOD

Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia

(2012) A. Scaradavou et al.   BLOOD

Haploidentical hematopoietic transplantation: current status and future perspectives

(2011) Y. Reisner et al.   BLOOD

Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

(2011) C. Ustun et al.   BLOOD

Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly

(2011) A. Veerapathran et al.   BLOOD

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation

(2011) M. Di Ianni et al.   BLOOD

Human FoxP3+ CD4+ regulatory T cells: their knowns and unknowns

(2011) Makoto Miyara et al.   IMMUNOLOGY AND CELL BIOLOGY

In vivo imaging of Treg cells providing immune privilege to the haematopoietic stem-cell niche

(2011) Joji Fujisaki et al.   NATURE

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

(2010) V. Gupta et al.   BLOOD

How I treat acute myeloid leukemia

(2010) J. M. Rowe et al.   BLOOD

Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics

(2010) C. G. Brunstein et al.   BLOOD

Different Proliferative Potential and Migratory Characteristics of Human CD4+ Regulatory T Cells That Express either CD45RA or CD45RO

(2010) N. J. Booth et al.   JOURNAL OF IMMUNOLOGY

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia

(2009) Q. Zhou et al.   BLOOD

Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: a tool for immunotherapy of leukemia

(2009) Andrea Velardi et al.   CURRENT OPINION IN IMMUNOLOGY

Characterizing and optimizing immune responses to leukaemia antigens after allogeneic stem cell transplantation

(2008) Katayoun Rezvani et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation

(2007) V. H. Nguyen et al.   BLOOD